Home/Filings/4/0001562180-20-005100
4//SEC Filing

Berman Robert 4

Accession 0001562180-20-005100

CIK 0001689813other

Filed

Jul 9, 8:00 PM ET

Accepted

Jul 10, 9:15 PM ET

Size

13.4 KB

Accession

0001562180-20-005100

Insider Transaction Report

Form 4
Period: 2020-07-08
Berman Robert
Chief Medical Officer
Transactions
  • Sale

    Common Shares

    2020-07-08$75.25/sh55,626$4,185,7453,119 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2020-07-0858,4040 total
    Exercise: $0.61Exp: 2024-11-25Common Shares (58,404 underlying)
  • Sale

    Common Shares

    2020-07-08$75.29/sh2,778$209,145341 total
  • Exercise/Conversion

    Common Shares

    2020-07-08$0.61/sh+58,404$35,62658,745 total
Holdings
  • Common Shares

    (indirect: By Spouse)
    50
  • Common Shares

    (indirect: By Trust)
    550,000
  • Common Shares

    (indirect: By Trust)
    240,500
Footnotes (4)
  • [F1]These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 - $75.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.00 - $76.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
  • [F4]The option, representing a right to purchase a total of 225,000 shares, was granted on November 26, 2014, and vested in four equal installments on November 26, 2014, 2015, 2016 and 2017

Issuer

Biohaven Pharmaceutical Holding Co Ltd.

CIK 0001689813

Entity typeother

Related Parties

1
  • filerCIK 0001704483

Filing Metadata

Form type
4
Filed
Jul 9, 8:00 PM ET
Accepted
Jul 10, 9:15 PM ET
Size
13.4 KB